Pre-treatment and post-treatment fertility in young male patients affected by Hodgkin and non-Hodgkin lymphoma

Nicolò De Luyk, Gabriele Pozzato, Giuseppe Ricci, Paolo Tamaro, Massimo Manno, Francesco Tomei, Carlo Trombetta

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: The aim of this study is to evaluate the fertility in young patients affected by Hodgkin and non-Hodgkin lymphoma, before and after chemotherapy and/or radiotherapy. We conducted a retrospective study to analyse how treatment affects male fertility and a perspective study to assess pre-treatment sperm quality. Materials and Methods: 28 patients, treated in our center or referred to our Medically Assisted Procreation Center, from 2002 to 2011, were selected for the retrospective study and asked if interested in their fertility assessment. Semen samples were taken from 11 patients (mean age 31.55: range 20-45); other possible causes of impaired fertility were excluded. We analyzed pretreatment semen samples of 61 patients (mean age 29.08 ± 9.5) affected by leukaemia or lymphoma that were selected for the perspective study and referred to the Sperm Bank of Pordenone. All semen samples were analysed accordingly to 1999 World Health Organization guidelines. Results: In the retrospective study all semen samples of the 11 patients selected were altered. Six patients treated with high dose alkylating agents and abdominal/pelvic radiotherapy were found azoospermic, 3 with severe oligoasthenozoospermic, 1 oligoteratozoospermic and 1 asthenozoospermic. In the perspective study pretreatment semen quality was poor in most of the samples of the 61 patients selected. Normozoospermia was observed in 14% of patients affected by Hodgkin lymphoma and in 25% affected by non-Hodgkin lymphoma. Conclusion: Chemotherapy, radiotherapy or their combination are followed by a temporary but sometimes irreversible reduction of fertility potential. Pre-treatment semen quality is acceptable to proceed with cyopreservation techniques. Sperm cryopreservation should be offered to all post puberal male patients who have not yet conceived before treatment with gonado-toxic agents.

Original languageEnglish
Pages (from-to)141-145
Number of pages5
JournalArchivio Italiano di Urologia e Andrologia
Volume84
Issue number3
Publication statusPublished - Sep 2012

Fingerprint

Hodgkin Disease
Non-Hodgkin's Lymphoma
Fertility
Semen
Semen Analysis
Radiotherapy
Therapeutics
Retrospective Studies
Spermatozoa
Sperm Banks
Drug Therapy
Poisons
Alkylating Agents
Cryopreservation
Lymphoma
Leukemia
Guidelines

Keywords

  • Chemotherapy
  • Cryopreservation
  • Fertility
  • Hodgkin lymphoma
  • Lymphoma
  • Non-Hodgkin lymphoma
  • Radiotherapy

ASJC Scopus subject areas

  • Urology

Cite this

Pre-treatment and post-treatment fertility in young male patients affected by Hodgkin and non-Hodgkin lymphoma. / De Luyk, Nicolò; Pozzato, Gabriele; Ricci, Giuseppe; Tamaro, Paolo; Manno, Massimo; Tomei, Francesco; Trombetta, Carlo.

In: Archivio Italiano di Urologia e Andrologia, Vol. 84, No. 3, 09.2012, p. 141-145.

Research output: Contribution to journalArticle

De Luyk, N, Pozzato, G, Ricci, G, Tamaro, P, Manno, M, Tomei, F & Trombetta, C 2012, 'Pre-treatment and post-treatment fertility in young male patients affected by Hodgkin and non-Hodgkin lymphoma', Archivio Italiano di Urologia e Andrologia, vol. 84, no. 3, pp. 141-145.
De Luyk, Nicolò ; Pozzato, Gabriele ; Ricci, Giuseppe ; Tamaro, Paolo ; Manno, Massimo ; Tomei, Francesco ; Trombetta, Carlo. / Pre-treatment and post-treatment fertility in young male patients affected by Hodgkin and non-Hodgkin lymphoma. In: Archivio Italiano di Urologia e Andrologia. 2012 ; Vol. 84, No. 3. pp. 141-145.
@article{c3f0dd28e3d240578188efffbf6d47b9,
title = "Pre-treatment and post-treatment fertility in young male patients affected by Hodgkin and non-Hodgkin lymphoma",
abstract = "Objectives: The aim of this study is to evaluate the fertility in young patients affected by Hodgkin and non-Hodgkin lymphoma, before and after chemotherapy and/or radiotherapy. We conducted a retrospective study to analyse how treatment affects male fertility and a perspective study to assess pre-treatment sperm quality. Materials and Methods: 28 patients, treated in our center or referred to our Medically Assisted Procreation Center, from 2002 to 2011, were selected for the retrospective study and asked if interested in their fertility assessment. Semen samples were taken from 11 patients (mean age 31.55: range 20-45); other possible causes of impaired fertility were excluded. We analyzed pretreatment semen samples of 61 patients (mean age 29.08 ± 9.5) affected by leukaemia or lymphoma that were selected for the perspective study and referred to the Sperm Bank of Pordenone. All semen samples were analysed accordingly to 1999 World Health Organization guidelines. Results: In the retrospective study all semen samples of the 11 patients selected were altered. Six patients treated with high dose alkylating agents and abdominal/pelvic radiotherapy were found azoospermic, 3 with severe oligoasthenozoospermic, 1 oligoteratozoospermic and 1 asthenozoospermic. In the perspective study pretreatment semen quality was poor in most of the samples of the 61 patients selected. Normozoospermia was observed in 14{\%} of patients affected by Hodgkin lymphoma and in 25{\%} affected by non-Hodgkin lymphoma. Conclusion: Chemotherapy, radiotherapy or their combination are followed by a temporary but sometimes irreversible reduction of fertility potential. Pre-treatment semen quality is acceptable to proceed with cyopreservation techniques. Sperm cryopreservation should be offered to all post puberal male patients who have not yet conceived before treatment with gonado-toxic agents.",
keywords = "Chemotherapy, Cryopreservation, Fertility, Hodgkin lymphoma, Lymphoma, Non-Hodgkin lymphoma, Radiotherapy",
author = "{De Luyk}, Nicol{\`o} and Gabriele Pozzato and Giuseppe Ricci and Paolo Tamaro and Massimo Manno and Francesco Tomei and Carlo Trombetta",
year = "2012",
month = "9",
language = "English",
volume = "84",
pages = "141--145",
journal = "Archivio Italiano di Urologia Nefrologia Andrologia",
issn = "1120-8538",
publisher = "Edizioni Scripta Manent s.n.c.",
number = "3",

}

TY - JOUR

T1 - Pre-treatment and post-treatment fertility in young male patients affected by Hodgkin and non-Hodgkin lymphoma

AU - De Luyk, Nicolò

AU - Pozzato, Gabriele

AU - Ricci, Giuseppe

AU - Tamaro, Paolo

AU - Manno, Massimo

AU - Tomei, Francesco

AU - Trombetta, Carlo

PY - 2012/9

Y1 - 2012/9

N2 - Objectives: The aim of this study is to evaluate the fertility in young patients affected by Hodgkin and non-Hodgkin lymphoma, before and after chemotherapy and/or radiotherapy. We conducted a retrospective study to analyse how treatment affects male fertility and a perspective study to assess pre-treatment sperm quality. Materials and Methods: 28 patients, treated in our center or referred to our Medically Assisted Procreation Center, from 2002 to 2011, were selected for the retrospective study and asked if interested in their fertility assessment. Semen samples were taken from 11 patients (mean age 31.55: range 20-45); other possible causes of impaired fertility were excluded. We analyzed pretreatment semen samples of 61 patients (mean age 29.08 ± 9.5) affected by leukaemia or lymphoma that were selected for the perspective study and referred to the Sperm Bank of Pordenone. All semen samples were analysed accordingly to 1999 World Health Organization guidelines. Results: In the retrospective study all semen samples of the 11 patients selected were altered. Six patients treated with high dose alkylating agents and abdominal/pelvic radiotherapy were found azoospermic, 3 with severe oligoasthenozoospermic, 1 oligoteratozoospermic and 1 asthenozoospermic. In the perspective study pretreatment semen quality was poor in most of the samples of the 61 patients selected. Normozoospermia was observed in 14% of patients affected by Hodgkin lymphoma and in 25% affected by non-Hodgkin lymphoma. Conclusion: Chemotherapy, radiotherapy or their combination are followed by a temporary but sometimes irreversible reduction of fertility potential. Pre-treatment semen quality is acceptable to proceed with cyopreservation techniques. Sperm cryopreservation should be offered to all post puberal male patients who have not yet conceived before treatment with gonado-toxic agents.

AB - Objectives: The aim of this study is to evaluate the fertility in young patients affected by Hodgkin and non-Hodgkin lymphoma, before and after chemotherapy and/or radiotherapy. We conducted a retrospective study to analyse how treatment affects male fertility and a perspective study to assess pre-treatment sperm quality. Materials and Methods: 28 patients, treated in our center or referred to our Medically Assisted Procreation Center, from 2002 to 2011, were selected for the retrospective study and asked if interested in their fertility assessment. Semen samples were taken from 11 patients (mean age 31.55: range 20-45); other possible causes of impaired fertility were excluded. We analyzed pretreatment semen samples of 61 patients (mean age 29.08 ± 9.5) affected by leukaemia or lymphoma that were selected for the perspective study and referred to the Sperm Bank of Pordenone. All semen samples were analysed accordingly to 1999 World Health Organization guidelines. Results: In the retrospective study all semen samples of the 11 patients selected were altered. Six patients treated with high dose alkylating agents and abdominal/pelvic radiotherapy were found azoospermic, 3 with severe oligoasthenozoospermic, 1 oligoteratozoospermic and 1 asthenozoospermic. In the perspective study pretreatment semen quality was poor in most of the samples of the 61 patients selected. Normozoospermia was observed in 14% of patients affected by Hodgkin lymphoma and in 25% affected by non-Hodgkin lymphoma. Conclusion: Chemotherapy, radiotherapy or their combination are followed by a temporary but sometimes irreversible reduction of fertility potential. Pre-treatment semen quality is acceptable to proceed with cyopreservation techniques. Sperm cryopreservation should be offered to all post puberal male patients who have not yet conceived before treatment with gonado-toxic agents.

KW - Chemotherapy

KW - Cryopreservation

KW - Fertility

KW - Hodgkin lymphoma

KW - Lymphoma

KW - Non-Hodgkin lymphoma

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84868112307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868112307&partnerID=8YFLogxK

M3 - Article

VL - 84

SP - 141

EP - 145

JO - Archivio Italiano di Urologia Nefrologia Andrologia

JF - Archivio Italiano di Urologia Nefrologia Andrologia

SN - 1120-8538

IS - 3

ER -